Table 1

Baseline characteristics of adults and children included in the cohort

AdultsChildren
N%N%
Death involving COVID-19118 2560.321<0.01
COVID-19 hospitalisation331 0630.929300.1
ICSNo asthma32 530 60292.4
No ICS565 1141.6
Low ICS1 451 4434.1
Medium ICS519 2941.5
High ICS136 0800.4
OCSNo asthma32 530 60292.42 780 63092.8
0 OCS2 072 4755.9197 8676.6
1 OCS307 4860.912 9440.4
2+ OCS291 9700.850620.2
SexFemale18 448 20452.41 470 95349.1
Male16 754 32947.61 525 55050.9
AgeMean51.014.9
SD19.01.7
Ethnic groupBangladeshi263 6240.748 0621.6
Black African528 6771.584 9712.8
Black Caribbean378 3141.126 8030.9
Chinese186 8410.512 1250.4
Indian939 9582.786 3802.9
Mixed566 1761.6150 8465.0
Other846 2872.4109 0423.6
Pakistani693 0452.0120 2824.0
White British29 074 17182.62 245 85074.9
White other1 725 4404.9112 1423.7
Quintile of Index of Multiple Deprivation16 478 68718.4662 54622.1
26 874 24719.5582 88119.5
37 189 51320.4562 07018.8
47 324 78420.8571 20619.1
57 335 30220.8617 80020.6
RegionNorth East1 767 9395.0138 8324.6
North West4 723 00713.4396 10113.2
Yorkshire and The Humber3 593 12910.2304 75210.2
East Midlands3 141 8268.9260 3318.7
West Midlands3 718 73310.6321 90910.7
East of England4 008 79511.4344 33211.5
London4 826 37213.7444 26614.8
South East5 770 90016.4498 72216.6
South West3 651 83210.4287 2589.6
Hospitalised in previous year (excluding for asthma)5 639 37516.0160 4635.4
Learning disabilityNone34 862 72399.0
Other learning disabilities332 5570.9
Down’s syndrome72530.02
Chronic kidney diseaseNone34 697 55698.6
CDK 3436 4521.2
CDK 445 6530.1
CDK 522 8720.1
Other conditionsDiabetes2 558 5037.3
COPD915 6982.6
Stroke513 5841.5
Atrial fibrillation797 0492.3
Congestive cardiac failure410 6921.2
Venous thromboembolism90120.03
Peripheral vascular disease166 9090.5
Dementia371 4541.1
Parkinson’s disease91 2590.3
Epilepsy192 5710.5
Severe mental illness3 249 2589.2
Osteoporotic fracture18 8910.1
Rheumatoid arthritis or systemic lupus erythematosus239 8410.7
Cirrhosis of the liver54 5850.2
  • CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; OCS, oral corticosteroids.